Can I use an ELN instead of a LIMS?
Wondering if an ELN can be used as a LIMS? Hear from IDBS and other experts in this interesting piece published in Lab Manager.
IDBS moves UK HQ to Woking
Global life sciences software company, IDBS, is excited to publicly announce the location of our new Surrey HQ office address in Woking.
Webinar | How to build a solid foundation for advanced analytics
Join us for an interesting roundtable discussion around how to build a solid foundation for advanced analytics and why legacy ELN/LIMS aren’t suitable for modern biopharma because they don’t support the data backbone concept. Hear from experts at Accenture, GSK and IDBS and gather insight from experiences close to the ever evolving market.
Advances in Biologics Require Advances in Data Management
Throughout the past few years, there’s been a clear trend in the makeup of approvals, with biologics representing a growing percentage. But even within biologics, newer technologies like mRNA, cell, and gene therapies are gaining ground. The approvals are not one-off events, but evidence of an exciting long-term trend. Learn more from Christian Marcazzo, General Manager at IDBS, in his article published in Drug Development & Discovery.
Tradeshow | Pharma Contract Manufacturing | March, 2022
IDBS will be presenting at the event this year in Berlin, Germany. We look forward to seeing you there!